BDBM50165946 3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-enylmethyl]-benzoic acid::CHEMBL192613

SMILES OC(=O)c1cccc(C[C@@H]2CCCC=C2c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1

InChI Key InChIKey=VIPZGFVAWMFKDS-QHCPKHFHSA-N

Data  8 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50165946   

TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi:  5.5nMAssay Description:Inhibition of [3H]-PGE-2 binding to human prostanoid EP4 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi:  610nMAssay Description:Inhibition of [3H]-Iloprost binding to human prostanoid IP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi:  2.50E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to human prostanoid EP1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to human prostanoid EP2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]-SQ-29,548 binding to human prostanoid TP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]-PGF-2 binding to human prostanoid FP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to human prostanoid EP3 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165946(3-[(S)-2-(4,5-Diphenyl-oxazol-2-yl)-cyclohex-2-eny...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibtion of [3H]-PGD-2 binding to human prostanoid DP receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed